Jefferies Cuts Price Target on Merck (MRK) to $56; Reiterates Hold

September 12, 2016 7:15 AM EDT
Get Alerts MRK Hot Sheet
Price: $61.38 -1.54%

Rating Summary:
    16 Buy, 6 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 9
Trade MRK Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Jefferies reiterated a Hold rating on Merck (NYSE: MRK), and cut the price target to $56.00 (from $57.00), as the company's growth remains constrained.

Analyst Jeffrey Holford commented, "MRK was over-rewarded for the failure of BMY's CM-026 study in our view. Whilst we see a c$3.3bn opportunity for Keytruda in NSCLC it is not enough to drive meaningful growth against upcoming LOEs. We expect competing IO combo data in 2017 will lower investor enthusiasm, though strong growth from Keytruda in Q4'16 may offset this to a degree."

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $62.49 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment